Sensus Healthcare (SRTS) Stock Forecast, Price Target & Predictions

OverviewRevenue Ownership Financials Chart Transcripts

SRTS Stock Forecast

Sensus Healthcare stock forecast is as follows: an average price target of $10.00 (represents a 45.35% upside from SRTS’s last price of $6.88) and a rating consensus of 'Buy', based on 3 wall street analysts offering a 1-year stock forecast.

SRTS Price Target

The average price target for Sensus Healthcare (SRTS) is $10.00 based on 1-year price targets from 3 Wall Street analysts in the past 3 months, with a price target range of $10.00 to $10.00. This represents a potential 45.35% upside from SRTS's last price of $6.88.

SRTS Analyst Ratings

Buy

According to 3 Wall Street analysts, Sensus Healthcare's rating consensus is 'Buy'. The analyst rating breakdown for SRTS stock is 0 'Strong Buy' (0.00%), 3 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Sensus Healthcare Price Target by Analyst

Date	Analyst	Company	Price Target	Price when Published	Price Target/Price when Published	Price Target/Last Closing Price
May 13, 2024	Raghuram Selvaraju	H.C. Wainwright	$10.00	$5.56	79.86%	45.35%
May 06, 2022	-	H.C. Wainwright	$16.00	$7.71	107.52%	132.56%

Row per page

Go to

The latest Sensus Healthcare stock forecast, released on May 13, 2024 by Raghuram Selvaraju from H.C. Wainwright, set a price target of $10.00, which represents a 79.86% increase from the stock price at the time of the forecast ($5.56), and a 45.35% increase from SRTS last price ($6.88).

Sensus Healthcare Price Target by Period

	1M	3M	12M
# Anlaysts	-	-	1
Avg Price Target	-	-	$10.00
Last Closing Price	$6.88	$6.88	$6.88
Upside/Downside	-100.00%	-100.00%	45.35%

In the current month, the average price target of Sensus Healthcare stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Sensus Healthcare's last price of $6.88. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades

Date	Company	Previous Rating	New Rating	Rating Change
May 13, 2024	H.C. Wainwright	Buy	Buy	Hold
May 04, 2023	Needham	Buy	Buy	Hold
Nov 04, 2022	Alliance Global Partners	Buy	Buy	Hold

Row per page

Go to

Sensus Healthcare's last stock rating was published by H.C. Wainwright on May 13, 2024. The company gave SRTS a "Buy" rating, the same as its previous rate.

Sensus Healthcare Financial Forecast

Sensus Healthcare Revenue Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	$12.57M	$3.90M	$4.53M	$3.41M	$13.11M	$9.01M	$12.08M	$10.34M	$13.03M	$5.53M	$5.42M	$3.07M	$5.09M	$1.62M	$1.18M	$1.68M	$8.51M	$5.84M
Avg Forecast	$11.40M	$8.80M	$9.70M	$9.00M	$14.28M	$9.37M	$10.89M	$10.67M	$11.23M	$5.90M	$7.00M	$4.68M	$12.06M	$5.90M	$4.55M	$10.07M	$12.97M	$9.54M	$9.56M	$6.73M	$11.08M	$5.40M	$4.28M	$3.69M	$2.53M	$2.04M	$1.44M	$5.19M	$8.59M	$7.44M
High Forecast	$11.40M	$8.80M	$9.70M	$9.00M	$14.28M	$9.37M	$10.89M	$10.67M	$11.23M	$6.38M	$7.00M	$4.78M	$12.06M	$6.92M	$4.55M	$10.07M	$12.97M	$9.54M	$9.56M	$6.73M	$11.08M	$5.40M	$4.28M	$3.69M	$2.53M	$2.04M	$1.44M	$5.19M	$8.59M	$7.44M
Low Forecast	$11.40M	$8.80M	$9.70M	$9.00M	$14.28M	$9.37M	$10.89M	$10.67M	$11.23M	$5.43M	$7.00M	$4.58M	$12.06M	$5.12M	$4.55M	$10.07M	$12.97M	$9.54M	$9.56M	$6.73M	$11.08M	$5.40M	$4.28M	$3.69M	$2.53M	$2.04M	$1.44M	$5.19M	$8.59M	$7.44M
# Analysts	1	1	1	1	1	1	1	1	1	2	1	1	1	5	4	4	3	3	3	3	4	4	4	4	4	5	9	6	4	4
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	1.04%	0.66%	0.99%	0.34%	1.01%	0.94%	1.26%	1.54%	1.18%	1.02%	1.27%	0.83%	2.02%	0.79%	0.82%	0.32%	0.99%	0.79%

Sensus Healthcare's average Quarter revenue forecast for Mar 24 based on 1 analysts is $4.68M, with a low forecast of $4.58M, and a high forecast of $4.78M. SRTS's average Quarter revenue forecast represents a -62.76% decrease compared to the company's last Quarter revenue of $12.57M (Dec 23).

Sensus Healthcare EBITDA Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	1	1	1	1	1	1	1	1	1	2	1	1	1	5	4	4	3	3	3	3	4	4	4	4	4	5	9	6	4	4
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	$5.64M	$-1.62M	$-1.13M	$-2.94M	$4.41M	$2.28M	$4.59M	$-8.85M	$5.32M	$322.00K	$-142.00K	$-907.00K	$1.25M	$-1.51M	$-2.41M	$-3.43M	$1.17M	$-596.43K
Avg Forecast	$-1.29M	$-998.18K	$-1.10M	$-1.02M	$-1.62M	$-1.06M	$-1.23M	$-1.21M	$-1.27M	$-669.73K	$-794.27K	$-2.39M	$-1.37M	$-669.28K	$-516.15K	$-1.89M	$2.91M	$-1.08M	$-1.08M	$-1.49M	$-1.26M	$-612.88K	$-485.54K	$-1.18M	$-286.66K	$-231.32K	$-162.81K	$-3.92M	$-973.80K	$-843.41K
High Forecast	$-1.29M	$-998.18K	$-1.10M	$-1.02M	$-1.62M	$-1.06M	$-1.23M	$-1.21M	$-1.27M	$-615.83K	$-794.26K	$-1.91M	$-1.37M	$-580.50K	$-516.15K	$-1.51M	$3.50M	$-1.08M	$-1.08M	$-1.19M	$-1.26M	$-612.88K	$-485.54K	$-943.28K	$-286.66K	$-231.32K	$-162.81K	$-3.14M	$-973.80K	$-843.41K
Low Forecast	$-1.29M	$-998.18K	$-1.10M	$-1.02M	$-1.62M	$-1.06M	$-1.23M	$-1.21M	$-1.27M	$-723.63K	$-794.29K	$-2.86M	$-1.37M	$-785.38K	$-516.15K	$-2.26M	$2.33M	$-1.08M	$-1.08M	$-1.79M	$-1.26M	$-612.88K	$-485.54K	$-1.41M	$-286.66K	$-231.32K	$-162.81K	$-4.71M	$-973.80K	$-843.41K
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-4.12%	2.42%	2.18%	1.56%	1.51%	-2.11%	-4.24%	5.93%	-4.23%	-0.53%	0.29%	0.77%	-4.37%	6.51%	14.82%	0.88%	-1.20%	0.71%

1 analysts predict SRTS's average Quarter EBITDA for Mar 24 to be $-2.39M, with a high of $-1.91M and a low of $-2.86M. This is -142.34% lower than Sensus Healthcare's previous annual EBITDA (Dec 23) of $5.64M.

Sensus Healthcare Net Income Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	1	1	1	1	1	1	1	1	1	2	1	1	1	5	4	4	3	3	3	3	4	4	4	4	4	5	9	6	4	4
Net Income	-	-	-	-	-	-	-	-	-	-	-	-	$4.21M	$-1.45M	$-380.00K	$-1.89M	$2.83M	$1.83M	$3.52M	$16.06M	$5.32M	$195.00K	$-279.00K	$-1.11M	$1.02M	$-1.69M	$-2.57M	$-3.59M	$1.04M	$-730.39K
Avg Forecast	$2.29M	$980.01K	$1.63M	$980.01K	$3.65M	$1.42M	$2.23M	$2.07M	$2.29M	$-163.33K	$381.11K	$-2.93M	$2.33M	$-294.00K	$-1.24M	$-2.32M	$2.91M	$2.06M	$2.16M	$-1.83M	$2.68M	$-272.23K	$-898.34K	$-1.45M	$-1.82M	$-2.21M	$-2.89M	$-4.10M	$462.78K	$-544.44K
High Forecast	$2.29M	$980.01K	$1.63M	$980.01K	$3.65M	$1.42M	$2.23M	$2.07M	$2.29M	$-81.67K	$383.83K	$-2.35M	$2.33M	$441.00K	$-1.24M	$-1.86M	$3.50M	$2.06M	$2.16M	$-1.47M	$2.68M	$-272.23K	$-898.34K	$-1.16M	$-1.82M	$-2.21M	$-2.89M	$-3.28M	$462.78K	$-544.44K
Low Forecast	$2.29M	$980.01K	$1.63M	$980.01K	$3.65M	$1.42M	$2.23M	$2.07M	$2.29M	$-163.33K	$378.39K	$-3.52M	$2.33M	$-735.01K	$-1.24M	$-2.78M	$2.33M	$2.06M	$2.16M	$-2.20M	$2.68M	$-272.23K	$-898.34K	$-1.74M	$-1.82M	$-2.21M	$-2.89M	$-4.92M	$462.78K	$-544.44K
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	1.81%	4.94%	0.31%	0.82%	0.97%	0.89%	1.63%	-8.76%	1.99%	-0.72%	0.31%	0.77%	-0.56%	0.77%	0.89%	0.88%	2.25%	1.34%

Sensus Healthcare's average Quarter net income forecast for Mar 24 is $-2.93M, with a range of $-3.52M to $-2.35M. SRTS's average Quarter net income forecast represents a -169.70% decrease compared to the company's last Quarter net income of $4.21M (Dec 23).

Sensus Healthcare SG&A Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	1	1	1	1	1	1	1	1	1	2	1	1	1	5	4	4	3	3	3	3	4	4	4	4	4	5	9	6	4	4
SG&A	-	-	-	-	-	-	-	-	-	-	-	-	$1.57M	$2.80M	$2.92M	$3.46M	$3.02M	$2.97M	$2.86M	$2.49M	$2.43M	$2.26M	$2.70M	$2.04M	$2.13M	$2.01M	$2.07M	$3.12M	$3.52M	$3.08M
Avg Forecast	$5.70M	$4.40M	$4.85M	$4.50M	$7.14M	$4.68M	$5.44M	$5.33M	$5.61M	$2.95M	$3.50M	$2.34M	$6.03M	$2.95M	$2.27M	$4.24M	$1.33M	$4.77M	$4.78M	$3.35M	$5.54M	$2.70M	$2.14M	$2.65M	$1.26M	$1.02M	$717.37K	$3.57M	$4.29M	$3.72M
High Forecast	$5.70M	$4.40M	$4.85M	$4.50M	$7.14M	$4.68M	$5.44M	$5.33M	$5.61M	$3.19M	$3.50M	$2.39M	$6.03M	$3.46M	$2.27M	$5.09M	$1.60M	$4.77M	$4.78M	$4.03M	$5.54M	$2.70M	$2.14M	$3.18M	$1.26M	$1.02M	$717.37K	$4.28M	$4.29M	$3.72M
Low Forecast	$5.70M	$4.40M	$4.85M	$4.50M	$7.14M	$4.68M	$5.44M	$5.33M	$5.61M	$2.71M	$3.50M	$2.29M	$6.03M	$2.56M	$2.27M	$3.40M	$1.07M	$4.77M	$4.78M	$2.68M	$5.54M	$2.70M	$2.14M	$2.12M	$1.26M	$1.02M	$717.37K	$2.85M	$4.29M	$3.72M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	0.26%	0.95%	1.29%	0.82%	2.27%	0.62%	0.60%	0.74%	0.44%	0.84%	1.26%	0.77%	1.69%	1.97%	2.88%	0.88%	0.82%	0.83%

Sensus Healthcare's average Quarter SG&A projection for Mar 24 is $2.34M, based on 1 Wall Street analysts, with a range of $2.29M to $2.39M. The forecast indicates a 48.60% rise compared to SRTS last annual SG&A of $1.57M (Dec 23).

Sensus Healthcare EPS Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	1	1	1	1	1	1	1	1	1	2	1	1	1	5	4	4	3	3	3	3	4	4	4	4	4	5	9	6	4	4
EPS	-	-	-	-	-	-	-	-	-	-	-	-	$0.26	$-0.09	$-0.02	$-0.12	$0.17	$0.11	$0.21	$0.97	$0.32	$0.01	$-0.02	$-0.07	$0.06	$-0.10	$-0.16	$-0.22	$0.06	$-0.04
Avg Forecast	$0.14	$0.06	$0.10	$0.06	$0.22	$0.09	$0.14	$0.13	$0.14	$-0.01	$0.02	$-0.04	$0.14	$-0.02	$-0.08	$0.13	$0.23	$0.13	$0.13	$0.04	$0.16	$-0.02	$-0.06	$-0.10	$-0.11	$-0.14	$-0.18	$-0.09	$0.03	$-0.03
High Forecast	$0.14	$0.06	$0.10	$0.06	$0.22	$0.09	$0.14	$0.13	$0.14	$-0.01	$0.02	$-0.04	$0.14	$0.03	$-0.08	$0.13	$0.23	$0.13	$0.13	$0.04	$0.16	$-0.02	$-0.06	$-0.10	$-0.11	$-0.14	$-0.18	$-0.09	$0.03	$-0.03
Low Forecast	$0.14	$0.06	$0.10	$0.06	$0.22	$0.09	$0.14	$0.13	$0.14	$-0.01	$0.02	$-0.04	$0.14	$-0.04	$-0.08	$0.13	$0.23	$0.13	$0.13	$0.04	$0.16	$-0.02	$-0.06	$-0.10	$-0.11	$-0.14	$-0.18	$-0.09	$0.03	$-0.03
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	1.82%	4.96%	0.31%	-0.96%	0.74%	0.87%	1.59%	22.38%	1.95%	-0.60%	0.36%	0.71%	-0.54%	0.74%	0.91%	2.59%	2.12%	1.20%

According to 1 Wall Street analysts, Sensus Healthcare's projected average Quarter EPS for Mar 24 is $-0.04, with a low estimate of $-0.04 and a high estimate of $-0.04. This represents a -116.67% decrease compared to SRTS previous annual EPS of $0.26 (Dec 23).

Sensus Healthcare Peer Comparison by Price Target

Ticker	Company	Last Closing Price	Avg Price Target	Upside/Downside	Avg Rating
AZYO	Elutia	$1.49	$10.25	587.92%	Buy
LUCD	Lucid Diagnostics	$1.05	$2.67	154.29%	Buy
SGHT	Sight Sciences	$3.98	$9.00	126.13%	Hold
LUNG	Pulmonx	$6.72	$11.93	77.53%	Buy
KIDS	OrthoPediatrics	$24.26	$39.60	63.23%	Buy
RXST	RxSight	$44.65	$70.11	57.02%	Buy
SRTS	Sensus Healthcare	$6.88	$10.00	45.35%	Buy
NPCE	NeuroPace	$9.15	$12.88	40.77%	Buy
OFIX	Orthofix Medical	$18.64	$24.00	28.76%	-
CVRX	CVRx	$14.20	$16.33	15.00%	Buy
CLPT	ClearPoint Neuro	$10.95	$12.00	9.59%	Buy
SRDX	Surmodics	$38.17	$39.50	3.48%	Buy
RCEL	AVITA Medical	$12.87	$9.00	-30.07%	Buy

SRTS Forecast FAQ

Is Sensus Healthcare a good buy?

Yes, according to 3 Wall Street analysts, Sensus Healthcare (SRTS) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 3 'Buy' recommendations, accounting for 100.00% of SRTS's total ratings.

What is SRTS's price target?

Sensus Healthcare (SRTS) average price target is $10 with a range of $10 to $10, implying a 45.35% from its last price of $6.88. The data is based on 3 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Sensus Healthcare stock go up soon?

According to Wall Street analysts' prediction for SRTS stock, the company can go up by 45.35% (from the last price of $6.88 to the average price target of $10), up by 45.35% based on the highest stock price target, and up by 45.35% based on the lowest stock price target.

Can Sensus Healthcare stock reach $10?

SRTS's average twelve months analyst stock price target of $10 does not support the claim that Sensus Healthcare can reach $10 in the near future.

What are Sensus Healthcare's analysts' financial forecasts?

Sensus Healthcare's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $45.21M (high $45.21M, low $45.21M), average EBITDA is $-5.128M (high $-5.128M, low $-5.128M), average net income is $9.36M (high $9.36M, low $9.36M), average SG&A $22.59M (high $22.59M, low $22.59M), and average EPS is $0.573 (high $0.573, low $0.573). SRTS's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $38.9M (high $38.9M, low $38.9M), average EBITDA is $-4.412M (high $-4.412M, low $-4.412M), average net income is $5.88M (high $5.88M, low $5.88M), average SG&A $19.44M (high $19.44M, low $19.44M), and average EPS is $0.36 (high $0.36, low $0.36).

Did the SRTS's actual financial results beat the analysts' financial forecasts?

Based on Sensus Healthcare's last annual report (Dec 2023), the company's revenue was $24.4M, which missed the average analysts forecast of $32.57M by -25.08%. Apple's EBITDA was $-107K, missing the average prediction of $-4.44M by -97.59%. The company's net income was $485K, missing the average estimation of $-1.527M by -131.75%. Apple's SG&A was $10.76M, missing the average forecast of $15.49M by -30.53%. Lastly, the company's EPS was $0.0298, missing the average prediction of $0.173 by -82.82%. In terms of the last quarterly report (Dec 2023), Sensus Healthcare's revenue was $12.57M, beating the average analysts' forecast of $12.06M by 4.21%. The company's EBITDA was $5.64M, missing the average prediction of $-1.368M by -512.14%. Sensus Healthcare's net income was $4.21M, beating the average estimation of $2.33M by 80.88%. The company's SG&A was $1.57M, missing the average forecast of $6.03M by -73.88%. Lastly, the company's EPS was $0.26, beating the average prediction of $0.142 by 82.46%